Retour sur lavenir.net
   AGEAS 71.900 € (-0,07 %)     AB INBEV 75.200 € (+1,95 %)     VASTNED 29.700 € (+0,68 %)     SOFINA 245.800 € (+1,15 %)     ONWARD MEDICAL 2.330 € (-2,10 %)     ARGENX SE 745.000 € (-0,21 %)     NYXOAH 1.220 € (-1,61 %)     UMICORE 21.600 € (+2,56 %)     BEKAERT 39.850 € (+1,53 %)     ASCENCIO 52.400 € (-0,19 %)     ACKERMANS V.HAAREN 269.200 € (-0,30 %)     FLUXYS BELGIUM D 20.300 € (+1,50 %)     VIOHALCO 17.680 € (+3,51 %)     BARCO 7.870 € (-0,51 %)     SHURGARD 25.350 € (0,00 %)     ECONOCOM GROUP 1.440 € (+3,60 %)     IBA 15.800 € (-0,63 %)     LOTUS BAKERIES 11 140.000 € (-1,76 %)     ORANGE BELGIUM 22.000 € (-0,45 %)     JENSEN-GROUP 84.600 € (+0,95 %)     SIPEF 90.700 € (-0,87 %)     CAMPINE 209.000 € (+1,46 %)     HOME INVEST BE. 20.150 € (-0,25 %)     AEDIFICA 70.250 € (-1,13 %)     ELIA GROUP 124.700 € (-0,87 %)     WDP 22.320 € (-0,18 %)     BREDERODE 103.000 € (0,00 %)     TESSENDERLO 21.350 € (+0,71 %)     XIOR 27.600 € (-1,25 %)     DEME GROUP 165.200 € (-0,96 %)     TINC 11.380 € (-0,18 %)     MATERIALISE 5.600 € (0,00 %)     RETAIL ESTATES 66.000 € (-0,90 %)     CIE BOIS SAUVAGE 305.000 € (+0,33 %)     D'IETEREN GROUP 179.400 € (-2,18 %)     GBL 78.150 € (-0,19 %)     TITAN S.A. 52.150 € (+2,76 %)     KINEPOLIS GROUP 40.500 € (-1,10 %)     KBC 124.650 € (+1,34 %)     SYENSQO 76.850 € (+1,18 %)     AZELIS GROUP 11.310 € (+0,09 %)     VGP 84.400 € (-0,82 %)     CMB.TECH 14.080 € (+2,33 %)     CENERGY 21.740 € (+2,45 %)     MELEXIS 68.300 € (-0,58 %)     RECTICEL 12.400 € (+2,99 %)     VAN DE VELDE 30.200 € (+0,67 %)     EVS 27.550 € (+0,36 %)     CARE PROPERTY INV. 12.640 € (-1,10 %)     SOLVAY 26.560 € (-1,56 %)     QUESTFOR GR-PRICAF 2.970 € (+2,41 %)     COLRUYT 39.040 € (+0,15 %)     AGFA-GEVAERT 0.385 € (+0,13 %)     PROXIMUS 6.425 € (+2,80 %)     GIMV 44.650 € (+0,56 %)     BIOTALYS 2.480 € (-0,20 %)     ENERGYVISION 15.200 € (+1,20 %)     UCB 222.900 € (+2,72 %)     DECEUNINCK 2.190 € (-1,35 %)     ONTEX GROUP 2.315 € (+7,42 %)  
   REXEL 35.840 € (0,00 %)     ASM INTERNATIONAL 801.200 € (+1,60 %)     DBV TECHNOLOGIES 2.350 € (-1,51 %)     SARTORIUS STED BIO 166.700 € (-2,00 %)     TIKEHAU CAPITAL 15.880 € (+1,40 %)     AMG 29.400 € (-0,27 %)     MEXEDIA 4.600 € (-11,88 %)     WE.CONNECT 25.500 € (0,00 %)     AIRBUS 202.200 € (-0,88 %)     AHOLD DEL 34.360 € (-0,81 %)     NN GROUP 81.600 € (+0,32 %)     ENGIE 27.110 € (+3,99 %)     INVENTIVA 3.800 € (-3,18 %)     GTT 195.700 € (-0,81 %)     ARCADIS 40.620 € (+1,80 %)     PUBLICIS GROUPE SA 92.620 € (-0,96 %)     SHELL PLC 39.720 € (+2,11 %)     LVMH 475.150 € (+0,39 %)     FDJ UNITED 21.930 € (-2,10 %)     KERING 284.200 € (-2,22 %)     HERMES INTL 1 531.500 € (-1,23 %)     AXA 44.940 € (-0,62 %)     ORDISSIMO 0.450 € (+9,76 %)     BE SEMICONDUCTOR 198.250 € (+0,38 %)     SANOFI 74.470 € (+2,34 %)     VIVENDI SE 1.596 € (-19,48 %)     AKWEL 6.600 € (+0,92 %)     HAFFNER ENERGY 0.325 € (+1,72 %)     VEOLIA ENVIRON. 34.470 € (-3,72 %)     SLIGRO FOOD GROUP 10.500 € (-1,50 %)     SCHNEIDER ELECTRIC 289.600 € (+1,76 %)     EXPLOSIFS PROD.CHI 265.000 € (-1,85 %)     ELEC.STRASBOURG 163.000 € (-16,75 %)     BUREAU VERITAS 27.660 € (-0,90 %)     CTP 15.580 € (-2,87 %)     ATOS GROUP 31.960 € (+2,44 %)     ASML HOLDING 1 434.200 € (-0,40 %)     KALRAY 7.000 € (-5,66 %)     MAGNUM 16.196 € (+0,24 %)     SEMCO TECHNOLOGIES 39.900 € (-1,85 %)     FLOW TRADERS 26.480 € (+2,72 %)     ABN AMRO BANK N.V. 39.000 € (+1,27 %)     LATECOERE 0.015 € (+4,23 %)     MANITOU BF 22.000 € (+10,00 %)     DBT 0.042 € (+0,48 %)     DERICHEBOURG 9.300 € (-1,06 %)     THALES 245.900 € (+1,07 %)     PHILIPS KON 22.740 € (-0,61 %)     ABIVAX 106.300 € (-2,03 %)     WINAMP GROUP 0.410 € (+3,67 %)     LLAMA GROUP 0.410 € (+3,67 %)     WENDEL 83.850 € (-0,47 %)     UNILEVER 55.740 € (-1,54 %)     UBISOFT ENTERTAIN 5.692 € (-2,57 %)     UMG 14.435 € (-25,40 %)     CREDIT AGRICOLE 19.275 € (+2,61 %)     ESSILORLUXOTTICA 164.050 € (+0,28 %)     BIOMERIEUX 69.100 € (-3,83 %)     BASIC-FIT 34.620 € (-3,03 %)     IMCD 94.780 € (-1,80 %)  
News Réglementées
30/06/2026 14:00

Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative

TORONTO, ON / ACCESS Newswire / June 30, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly owned subsidiary, QuantIP Licensing Corp. (formerly Paymetrex Payment Solutions Inc.), has completed an evaluation of 2 patents from its intellectual property portfolio using 2 artificial intelligence-driven patent analytics platforms.

The evaluation focused on U.S. Patent No. 9,275,015 and U.S. Patent No. 9,665,561, both of which claim a 2012 priority date and relate generally to systems and methods for analyzing large volumes of information, including temporally ordered datasets such as social media, electronic communications, and other digital information sources. The Company notes that techniques for clustering and organizing large volumes of social media and other digital communications data have become foundational to the development and training of large language models. LLMs depend on the ingestion, organization, and semantic analysis of temporally ordered datasets - including social media content - to develop language understanding and generate contextually relevant outputs. Management believes that the methods described in the Company's patents, which address the organization and analysis of such datasets using clustering and semantic analysis techniques, are pertinent to processes that are now widely employed in the development and operation of LLM-based applications.

These patents are expected to expire in 2032, subject to any patent term extensions that may be granted by the USPTO. The patents were analyzed using the proprietary evaluation methodologies of Pelent AI and VisiLeap, 2 artificial intelligence-driven patent analytics platforms. No fees were paid by the Company in connection with these evaluations. The assessments considered factors including technological relevance, claim strength, commercial applicability, and potential licensing opportunities. These AI-generated analyses were used as one of several inputs in management's evaluation of the Company's intellectual property strategy, alongside internal technical review and market analysis.

Greg Waite, CEO of InventonShare and the inventor of the VisiLeap platform, has indicated that, in his view, the patents relate to techniques that have been adopted across a number of artificial intelligence and data analytics applications. Mr. Waite's opinion was provided in his capacity as the developer of the VisiLeap platform and should be read in that context. The Company intends to explore licensing opportunities with organizations whose products or services may utilize technologies that may fall within the scope of the Company's patent portfolio.

Based on these evaluations, QuantIP has initiated preparations for a structured licensing program. No potential licensees have been identified, no licensing discussions are underway, and no infringement analyses have been completed as of the date of this release. There is no assurance that the licensing program will result in executed agreements or generate revenues.

The licensing initiative is intended to complement QuantIP's existing intellectual property monetization activities and reflects the Company's broader strategy of leveraging artificial intelligence to identify commercialization opportunities across its intellectual property assets. The Company intends to utilize AI-assisted patent intelligence tools together with conventional licensing analysis to identify potential licensing candidates and evaluate complementary intellectual property acquisition opportunities.

"Artificial intelligence is becoming an increasingly useful tool for evaluating intellectual property portfolios," said Michael Kron, Chief Operating Officer of Datametrex AI Limited. "The analyses generated by Pelent AI and VisiLeap, combined with our own internal review, support management's decision to proceed with a structured licensing program in relation to these patents. We intend to use AI-driven patent intelligence tools as one component of our licensing process."

The Company's two information analytics patents address technologies for organizing, analyzing, and identifying relationships within large volumes of digital information using semantic analysis, temporal organization, clustering, and trend identification techniques. Management believes these techniques continue to be relevant across a range of software applications, including enterprise analytics, cybersecurity, digital communications, and information management. The Company intends to conduct further analysis to identify specific sectors and organizations where licensing may be applicable.

About QuantIP Licensing Corp.

QuantIP Licensing Corp., a wholly owned subsidiary of Datametrex AI Limited, is focused on the acquisition, development, licensing, and monetization of intellectual property relating to payment technologies, artificial intelligence, cybersecurity, data analytics, and emerging quantum encryption applications.

About InventionShare

InventionShare monetizes technologies directly through licensing or acquisition. The Company identifies and cultivates attractive monetization opportunities by leveraging its unique toolbox of capabilities that includes:

Relationships. An extensive network of high-value industry connections.

Analysis. Big data tools such as VisiLeap for analyzing patents to assess technology strength and fit with target markets and companies.

Marketing. Crafting compelling IP marketing stories and IP branding that is tailored for specific audiences.

About Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our Company website (www.datametrex.com).

For Additional Information

Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking information within the meaning of applicable Canadian securities legislation, including statements regarding the Company's proposed licensing program, anticipated licensing opportunities, commercialization initiatives, and the potential applicability of its patent portfolio to artificial intelligence, data analytics, and related markets.

The patent analyses referenced in this news release were generated using Pelent AI and VisiLeap, artificial intelligence-based patent analytics platforms. These analyses are intended to assist in evaluating certain characteristics of patent assets and should not be interpreted as independent appraisals, formal valuations, legal opinions, or guarantees of patent validity, enforceability, infringement, future licensing revenue, or commercial success. No potential licensees have been identified, no licensing discussions are underway, and no infringement analyses have been completed as of the date of this release.

There can be no assurance that the Company will identify parties interested in licensing its patents, that any licensing discussions will result in executed agreements, or that any licensing program will generate material revenues. Actual results may differ materially from those expressed or implied by the forward-looking information contained herein. Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update such statements except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

###

SOURCE: DataMetrex AI Ltd.



View the original press release on ACCESS Newswire

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière